Lee Financial CO Gilead Sciences, Inc. Transaction History

Lee Financial CO

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$73.27 - $83.09 $6,154 - $6,979	84 Added 36.05%	317 $25,000
Q2 2023 Aug 08, 2023	BUY	$76.01 - $86.7 $9,881 - $11,271	130 Added 126.21%	233 $17,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $1,468 - $1,673	-19 Reduced 15.57%	103 $8,000
Q3 2022 Nov 01, 2022	BUY	$59.54 - $68.01 $2,441 - $2,788	41 Added 50.62%	122 $7,000
Q2 2022 Aug 10, 2022	BUY	$57.72 - $65.01 $2,135 - $2,405	37 Added 84.09%	81 $5,000
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $126,265 - $158,224	-2,180 Reduced 98.02%	44 $3,000
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $3,892 - $4,418	60 Added 2.77%	2,224 $161,000
Q2 2021 Aug 04, 2021	SELL	$63.47 - $69.35 $6,473 - $7,073	-102 Reduced 4.5%	2,164 $149,000
Q1 2021 May 13, 2021	BUY	$60.0 - $68.46 $60 - $68	1 Added 0.04%	2,266 $146,000
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $5,721 - $6,519	101 Added 4.67%	2,265 $132,000
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $135,531 - $173,596	2,164 New	2,164 $162,000
Q2 2019 Jul 30, 2019	SELL	$61.87 - $69.38 $37,122 - $41,628	-600 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$71.28 - $78.92 $11,903 - $13,179	167 Added 38.57%	600 $46,000
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $64 - $75	1 Added 0.23%	433 $31,000
Q1 2018 May 09, 2018	BUY	$72.84 - $88.8 $20,832 - $25,396	286 Added 195.89%	432 $32,000
Q4 2017 Feb 09, 2018	BUY	$71.15 - $83.52 $7,968 - $9,354	112 Added 329.41%	146 $10,000
Q3 2017 Nov 07, 2017	BUY	$72.11 - $85.47 $2,451 - $2,905	34	34 $3,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.